211 related articles for article (PubMed ID: 27871965)
1. Molecular interplay between mutant p53 proteins and autophagy in cancer cells.
Cordani M; Butera G; Pacchiana R; Donadelli M
Biochim Biophys Acta Rev Cancer; 2017 Jan; 1867(1):19-28. PubMed ID: 27871965
[TBL] [Abstract][Full Text] [Related]
2. Mutant p53 proteins counteract autophagic mechanism sensitizing cancer cells to mTOR inhibition.
Cordani M; Oppici E; Dando I; Butturini E; Dalla Pozza E; Nadal-Serrano M; Oliver J; Roca P; Mariotto S; Cellini B; Blandino G; Palmieri M; Di Agostino S; Donadelli M
Mol Oncol; 2016 Aug; 10(7):1008-29. PubMed ID: 27118659
[TBL] [Abstract][Full Text] [Related]
3. Mutant p53 and mTOR/PKM2 regulation in cancer cells.
Dando I; Cordani M; Donadelli M
IUBMB Life; 2016 Sep; 68(9):722-6. PubMed ID: 27385486
[TBL] [Abstract][Full Text] [Related]
4. Proteasomal and autophagy-mediated degradation of mutp53 proteins through mitochondria-targeting aggregation-induced-emission materials.
Wang M; Yang Z; Song Y; Wei P; Ishiwme N; Wang L; Zhang H; Jing M; Gao M; Wen L; Zhang Y
Acta Biomater; 2022 Sep; 150():402-412. PubMed ID: 35931280
[TBL] [Abstract][Full Text] [Related]
5. Chaperone-mediated autophagy degrades mutant p53.
Vakifahmetoglu-Norberg H; Kim M; Xia HG; Iwanicki MP; Ofengeim D; Coloff JL; Pan L; Ince TA; Kroemer G; Brugge JS; Yuan J
Genes Dev; 2013 Aug; 27(15):1718-30. PubMed ID: 23913924
[TBL] [Abstract][Full Text] [Related]
6. A degradative detour for mutant TP53.
Vakifahmetoglu-Norberg H; Yuan J
Autophagy; 2013 Dec; 9(12):2158-60. PubMed ID: 24145670
[TBL] [Abstract][Full Text] [Related]
7. Allele-specific silencing of mutant p53 attenuates dominant-negative and gain-of-function activities.
Iyer SV; Parrales A; Begani P; Narkar A; Adhikari AS; Martinez LA; Iwakuma T
Oncotarget; 2016 Feb; 7(5):5401-15. PubMed ID: 26700961
[TBL] [Abstract][Full Text] [Related]
8. Mutant p53 as a Regulator and Target of Autophagy.
Shi Y; Norberg E; Vakifahmetoglu-Norberg H
Front Oncol; 2020; 10():607149. PubMed ID: 33614491
[TBL] [Abstract][Full Text] [Related]
9. p53-Dependent PUMA to DRAM antagonistic interplay as a key molecular switch in cell-fate decision in normal/high glucose conditions.
Garufi A; Pistritto G; Baldari S; Toietta G; Cirone M; D'Orazi G
J Exp Clin Cancer Res; 2017 Sep; 36(1):126. PubMed ID: 28893313
[TBL] [Abstract][Full Text] [Related]
10. Mutant p53 gain of function can be at the root of dedifferentiation of human osteosarcoma MG63 cells into 3AB-OS cancer stem cells.
Di Fiore R; Marcatti M; Drago-Ferrante R; D'Anneo A; Giuliano M; Carlisi D; De Blasio A; Querques F; Pastore L; Tesoriere G; Vento R
Bone; 2014 Mar; 60():198-212. PubMed ID: 24373920
[TBL] [Abstract][Full Text] [Related]
11. S100A4 interacts with mutant p53 and affects gastric cancer MKN1 cell autophagy and differentiation.
Shen W; Chen D; Liu S; Chen L; Yu A; Fu H; Sun X
Int J Oncol; 2015 Dec; 47(6):2123-30. PubMed ID: 26497012
[TBL] [Abstract][Full Text] [Related]
12. Gambogic acid counteracts mutant p53 stability by inducing autophagy.
Foggetti G; Ottaggio L; Russo D; Monti P; Degan P; Fronza G; Menichini P
Biochim Biophys Acta Mol Cell Res; 2017 Feb; 1864(2):382-392. PubMed ID: 27899303
[TBL] [Abstract][Full Text] [Related]
13. Reactivation of mutant p53 by capsaicin, the major constituent of peppers.
Garufi A; Pistritto G; Cirone M; D'Orazi G
J Exp Clin Cancer Res; 2016 Sep; 35(1):136. PubMed ID: 27599722
[TBL] [Abstract][Full Text] [Related]
14. Mutant p53-Associated Molecular Mechanisms of ROS Regulation in Cancer Cells.
Cordani M; Butera G; Pacchiana R; Masetto F; Mullappilly N; Riganti C; Donadelli M
Biomolecules; 2020 Feb; 10(3):. PubMed ID: 32111081
[TBL] [Abstract][Full Text] [Related]
15. PRIMA-1 induces autophagy in cancer cells carrying mutant or wild type p53.
Russo D; Ottaggio L; Foggetti G; Masini M; Masiello P; Fronza G; Menichini P
Biochim Biophys Acta; 2013 Aug; 1833(8):1904-13. PubMed ID: 23545415
[TBL] [Abstract][Full Text] [Related]
16. p53-mediated autophagic regulation: A prospective strategy for cancer therapy.
Tang J; Di J; Cao H; Bai J; Zheng J
Cancer Lett; 2015 Jul; 363(2):101-7. PubMed ID: 25896632
[TBL] [Abstract][Full Text] [Related]
17. Mutant p53 potentiates the oncogenic effects of insulin by inhibiting the tumor suppressor DAB2IP.
Valentino E; Bellazzo A; Di Minin G; Sicari D; Apollonio M; Scognamiglio G; Di Bonito M; Botti G; Del Sal G; Collavin L
Proc Natl Acad Sci U S A; 2017 Jul; 114(29):7623-7628. PubMed ID: 28667123
[TBL] [Abstract][Full Text] [Related]
18. Contribution of autophagic cell death to p53-dependent cell death in human glioblastoma cell line SF126.
Sakamoto Y; Kato S; Takahashi M; Okada Y; Yasuda K; Watanabe G; Imai H; Sato A; Ishioka C
Cancer Sci; 2011 Apr; 102(4):799-807. PubMed ID: 21214676
[TBL] [Abstract][Full Text] [Related]
19. Targeting mutant p53 in cancer: a long road to precision therapy.
Mantovani F; Walerych D; Sal GD
FEBS J; 2017 Mar; 284(6):837-850. PubMed ID: 27808469
[TBL] [Abstract][Full Text] [Related]
20. Mutant p53 proteins alter cancer cell secretome and tumour microenvironment: Involvement in cancer invasion and metastasis.
Cordani M; Pacchiana R; Butera G; D'Orazi G; Scarpa A; Donadelli M
Cancer Lett; 2016 Jul; 376(2):303-9. PubMed ID: 27045472
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
